Wuxi Tongshu Biotechnology

Tongshu Bio is a high-tech enterprise specializing in precision medicine and molecular diagnostics, with a primary focus on oncology. The company provides comprehensive solutions for cancer screening, companion diagnostics, and dynamic monitoring using advanced next-generation sequencing (NGS) and liquid biopsy technologies. Tongshu Bio has developed a robust portfolio of proprietary products, including multi-gene testing kits for various solid tumors and specialized assays for minimal residual disease (MRD) detection. Operating out of a CAP-certified and CLIA-compliant laboratory, the company collaborates closely with hospitals and pharmaceutical companies to deliver personalized treatment insights. Their business model integrates research and development, manufacturing, and clinical testing services to advance the standard of care in cancer treatment.